Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-11-29 | 2021-12-09 | 150178 |
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2022-02-22 | 2022-03-09 | 155365 |
| APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2019-03-05 | 2019-04-26 | 77899 |
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2017-03-11 | 2017-04-12 | 534 |
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2018-04-16 | 2018-08-18 | 46046 |
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-05-28 | 2021-07-30 | 140078 |
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-17 | 160144 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-07-27 | 2023-08-23 | 200191 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2023-11-17 | 2024-02-02 | 210725 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-10-19 | 2018-11-22 | 65005 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-11-10 | 2024-02-02 | 209961 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-03-20 | 2017-03-24 | 3539 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-04-16 | 2018-05-22 | 46006 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2021-08-03 | 2021-08-16 | 143404 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2017-10-23 | 2018-01-31 | 26662 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-05-03 | 2025-01-03 | 227031 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2018-03-20 | 2019-01-18 | 43519 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-06-13 | 2025-03-07 | 230350 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-10-18 | 2018-01-31 | 26224 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2020-05-08 | 2020-06-15 | 114324 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |